A detailed history of Farther Finance Advisors, LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 1 shares of NKTX stock, worth $2. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 1 -0.0%
Holding current value
$2
Previous $6,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$5.27 - $10.82 $89 - $183
-17 Reduced 94.44%
1 $6,000
Q1 2024

May 13, 2024

BUY
$5.59 - $15.71 $95 - $267
17 Added 1700.0%
18 $195,000
Q4 2023

Feb 14, 2024

BUY
$1.31 - $6.6 $1 - $6
1 New
1 $7,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $118M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.